Hyperfine, Inc. (HYPR)
0.8126
+0.02
(+2.10%)
USD |
NASDAQ |
Sep 25, 14:21
Hyperfine Enterprise Value : 53.05M for Sept. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 24, 2026 | 53.05M |
| September 23, 2026 | 52.42M |
| September 22, 2026 | 54.02M |
| September 21, 2026 | 51.48M |
| September 18, 2026 | 51.86M |
| September 17, 2026 | 50.60M |
| September 16, 2026 | 50.75M |
| September 15, 2026 | 53.61M |
| September 14, 2026 | 53.91M |
| September 11, 2026 | 52.43M |
| September 10, 2026 | 52.04M |
| September 09, 2026 | 52.52M |
| September 08, 2026 | 55.79M |
| September 04, 2026 | 54.89M |
| September 03, 2026 | 57.41M |
| September 02, 2026 | 54.12M |
| September 01, 2026 | 54.62M |
| August 31, 2026 | 56.06M |
| August 28, 2026 | 57.00M |
| August 27, 2026 | 58.30M |
| August 26, 2026 | 60.70M |
| August 25, 2026 | 60.88M |
| August 24, 2026 | 59.45M |
| August 21, 2026 | 64.31M |
| August 20, 2026 | 64.52M |
| Date | Value |
|---|---|
| August 19, 2026 | 64.28M |
| August 18, 2026 | 63.63M |
| August 17, 2026 | 63.64M |
| August 14, 2026 | 63.33M |
| August 13, 2026 | 63.38M |
| August 12, 2026 | 64.15M |
| August 11, 2026 | 71.05M |
| August 10, 2026 | 69.39M |
| August 07, 2026 | 69.92M |
| August 06, 2026 | 72.78M |
| August 05, 2026 | 72.57M |
| August 04, 2026 | 76.81M |
| August 03, 2026 | 72.70M |
| July 31, 2026 | 67.88M |
| July 30, 2026 | 67.08M |
| July 29, 2026 | 63.13M |
| July 28, 2026 | 65.74M |
| July 27, 2026 | 70.50M |
| July 24, 2026 | 69.80M |
| July 23, 2026 | 69.79M |
| July 22, 2026 | 72.42M |
| July 21, 2026 | 73.78M |
| July 20, 2026 | 72.41M |
| July 17, 2026 | 67.34M |
| July 16, 2026 | 72.79M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 202.55B |
| AngioDynamics, Inc. | 594.27M |
| Alphatec Holdings, Inc. | 2.024B |
| AtriCure, Inc. | 2.997B |
| Baxter International, Inc. | 18.82B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.298M |
| Revenue (Quarterly) | 3.904M |
| Total Expenses (Quarterly) | 13.20M |
| EPS Diluted (Quarterly) | -0.0932 |
| Gross Profit Margin (Quarterly) | 50.72% |
| Profit Margin (Quarterly) | -238.2% |
| Earnings Yield | -47.22% |
| Normalized Earnings Yield | -45.34 |